Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calvert Street Investment Partners is a lower middle-market private equity and credit firm with two complementary investment strategies: Crescentia Capital (equity buyout) and Parkway Capital (mezzanine debt). The firm invests in industrial services, business services, specialty manufacturing, and related sectors—not healthcare or biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calvert Street Investment Partners.